These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 7664822

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
    Seeman P, Ko F, Willeit M, McCormick P, Ginovart N.
    Synapse; 2005 Nov; 58(2):122-8. PubMed ID: 16088951
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists.
    Piercey MF, Hoffmann WE, Smith MW, Hyslop DK.
    Eur J Pharmacol; 1996 Sep 19; 312(1):35-44. PubMed ID: 8891576
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
    Maj J, Rogóz Z, Skuza G, Kołodziejczyk K.
    Eur J Pharmacol; 1997 Apr 11; 324(1):31-7. PubMed ID: 9137910
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of binding of [3H]PD 128907, a selective dopamine D3 receptor agonist ligand, to CHO-K1 cells.
    Akunne HC, Towers P, Ellis GJ, Dijkstra D, Wikström H, Heffner TG, Wise LD, Pugsley TA.
    Life Sci; 1995 Apr 11; 57(15):1401-10. PubMed ID: 7674830
    [Abstract] [Full Text] [Related]

  • 17. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
    Hidaka K, Tada S, Matsumoto M, Ohmori J, Tasaki Y, Nomura T, Usuda S, Yamaguchi T.
    Br J Pharmacol; 1996 Apr 11; 117(8):1625-32. PubMed ID: 8732269
    [Abstract] [Full Text] [Related]

  • 18. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.
    Siuciak JA, Fujiwara RA.
    Psychopharmacology (Berl); 2004 Sep 11; 175(2):163-9. PubMed ID: 14985923
    [Abstract] [Full Text] [Related]

  • 19. A functional test identifies dopamine agonists selective for D3 versus D2 receptors.
    Sautel F, Griffon N, Lévesque D, Pilon C, Schwartz JC, Sokoloff P.
    Neuroreport; 1995 Jan 26; 6(2):329-32. PubMed ID: 7756621
    [Abstract] [Full Text] [Related]

  • 20. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 26; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.